杜拉鲁肽
医学
2型糖尿病
内科学
心脏病学
糖尿病
心力衰竭
血压
利钠肽
2型糖尿病
动脉粥样硬化性心血管疾病
疾病
作者
Stephen J. Nicholls,Imre Pávó,Deepak L. Bhatt,John B. Buse,Stefano Del Prato,Steven E. Kahn,A. Michael Lincoff,Darren K. McGuire,Debra L. Miller,Michael A. Nauck,Hiroshi Nishiyama,Steven E. Nissen,Naveed Sattar,Govinda Weerakkody,Russell J. Wiese,Bernard Zinman,Sophia Zoungas,Jan Basile,Melanie J Davies,Francesco Giorgino
标识
DOI：10.1056/nejmoa2505928
摘要
Among patients with type 2 diabetes and atherosclerotic cardiovascular disease, tirzepatide was noninferior to dulaglutide with respect to a composite of death from cardiovascular causes, myocardial infarction, or stroke. (Funded by Eli Lilly; SURPASS-CVOT ClinicalTrials.gov number, NCT04255433.).
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
Twonej
无极微光
蓝天
pluto
dew
大力的灵雁
蓝莓橘子酱
lizishu
simple
乐空思
8R60d8
陈平安
子车茗
Dean
zhonglv7
昏睡的蟠桃
殷勤的紫槐
杨文化
lyb
美好乐松
皖公网安备34019202002308
